What is the Gilead Sciences market cap?

Gilead Sciences market cap history and chart from 2010 to 2022. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Gilead Sciences market cap as of April 14, 2023 is $102.6B.

Does NASDAQ use Gilead Sciences (gild) stock to determine compliance?

NASDAQ does not use this value to determine compliance with the listing requirements. Gilead Sciences, Inc. Common Stock (GILD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Why should you buy a Gilead index fund?

Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology. By buying an index fund, investors can approximate the average market return.

What is market cap (capitalization)?

Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data.nasdaq.com . Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent.